HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Royce Ma Selected Research

Therapeutics

12/2023Anti-tumor Efficacy and Safety of Unedited Autologous CD5.CAR T cells in Relapsed/Refractory Mature T-cell Lymphomas.
1/2023Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies.
1/2021Engineered off-the-shelf therapeutic T cells resist host immune rejection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Royce Ma Research Topics

Disease

4Neoplasms (Cancer)
12/2023 - 10/2018
3Chronic Obstructive Pulmonary Disease (COPD)
01/2017 - 06/2014
2Fibrosis (Cirrhosis)
01/2017 - 04/2015
1T-Cell Lymphoma (Lymphoma, T Cell)
12/2023
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2023
1Inflammation (Inflammations)
01/2017
1Airway Remodeling
06/2014

Drug/Important Bio-Agent (IBA)

3Chimeric Antigen ReceptorsIBA
03/2024 - 01/2021
2AntigensIBA
12/2023 - 01/2023
2IntegrinsIBA
10/2018 - 06/2014
1ChemokinesIBA
10/2018
1AntibodiesIBA
10/2018
1Interleukin-17 ReceptorsIBA
01/2017
1Protein Isoforms (Isoforms)IBA
01/2017
1Interleukin-17 (Interleukin 17)IBA
01/2017
1SmokeIBA
08/2015
1LigandsIBA
08/2015
1Chemokine ReceptorsIBA
04/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
06/2014

Therapy/Procedure

3Therapeutics
12/2023 - 01/2021